Bench:T.S. Thakur
6 IP cases indexed. Covers patent, trademark matters.
Cases Presided Over
6 cases indexed | Page 1 of 1
Eureka Forbes Ltd. v.Hindustan Unilever Ltd.
The appeal challenged the Single Judge's decision to allow a suit for patent infringement. The court examined whether the plaint disclosed a cause of action, particularly when the suit was filed against another patentee. The High Court held that the plaint did disclose a cause of action and dismissed the appeal.
Larsen And Toubro Ltd. v.Lachmi Narain Trades And Ors
The Delhi High Court ruled in favor of Larsen And Toubro Ltd., granting a permanent injunction against the defendants for passing off. The court found that L&T's name and abbreviation, having acquired distinctiveness over decades, were being used by the defendants (using marks like 'LNT'/'ELENTE') to sell electrical goods, thereby causing confusion among the public. This judgment reinforces the principle of protecting established goodwill and reputation against deceptive trade practices.
Yash Arora v.Tushar Enterprises And Ors.
The Delhi High Court allowed an appeal challenging the vacation of an interim injunction granted in a trademark infringement suit. The plaintiff, claiming prior use of 'KEYMAN' since 1985, faced challenges regarding documentary evidence and alleged negligence in not knowing about the defendant's earlier registered mark, 'KEY MANN'. However, the appellate court found that the single judge's dismissal of the prior user claim was unsatisfactory. Consequently, the appeal succeeded, setting aside the vacation order and remitting the matter back for a fresh determination on the prima facie case.
Reddy Pharmaceuticals Ltd. v.Dr. Reddy'S Laboratories Ltd.
The Delhi High Court dismissed an appeal, upholding the injunction granted against Dr. Reddy's Laboratories Ltd. The case centered on whether the defendant was passing off its products by using a deceptively similar name and logo ('Reddy') that accrued goodwill to the plaintiff's established trademark 'Dr. Reddy'. The court affirmed that while the defendant had initially been an agent, its subsequent entry into manufacturing finished dosage forms under the disputed brand constituted infringement. The judgment emphasized that even if alternative views were possible on the facts, appellate courts should not interfere with a trial court's properly exercised discretion. This ruling reinforces the importance of protecting established trade names and goodwill in the pharmaceutical sector.
G.D. Searle Llc And Ors. v.Maiden Pharmaceuticals Ltd.
The Delhi High Court addressed applications for ad interim injunction concerning the anti-diarrhea drug LOMOTIL. The court found considerable merit in the plaintiffs' claims that the defendants' products (MICROTIL and MONOTIL) were deceptively similar to LOMOTIL, particularly regarding trade dress, packaging, and color scheme. However, instead of outright banning the defendant's trademarks, the court modified the existing injunctions. The defendants are permitted to market their products under their respective names, provided they significantly alter their product's visual appearance (trade dress) to avoid consumer confusion.
Microsoft Corporation v.Ashok Azad And Ors.
This case involved Microsoft Corporation, the owner of copyrighted computer software and registered trademarks, suing various computer training institutes for using pirated software. After initial injunctions were granted, the parties reached an amicable settlement which included undertakings by the respondents to cease infringement and legalize their software use. The subsequent petitions filed before the court sought contempt action based on alleged breaches of these undertakings. However, the Delhi High Court dismissed the petitions, ruling that since the undertaking was given only to the plaintiffs (the opposing party) and not directly to the court, it did not constitute a breach actionable under contempt jurisdiction.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.